During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical ...

Phages are particularly advantageous anti-infectives as they are novel therapeutics, can target antibiotic-resistant bacteria ...

Researchers have just identified a powerful new antibiotic – in a significant discovery made not by breaking new ground, but ...

US clinical stage biotech Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in ...

SA02, demonstrated earlier resolution in patients with Staphylococcus aureus bacteremia (SAB) in a Phase IIa trial, reinforcing the growing clinical promise of bacteriophage-based treatments. The ...

Patients staying in hospital rooms with multiple beds are at an increased risk — up to ninefold higher — for Staphylococcus ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Researchers at University of California San Diego School of Medicine have discovered a previously unrecognized mechanism by which Staphylococcus aureus—one of the most common causes of skin and soft ...

What makes S. aureus so dangerous? The virulence of S. aureus lies in its ability to adapt to environmental pressures and immune defenses quickly. A central feature of its survival strategy is the ...

Fourteen people fell sick in a Staphylococcus aureus outbreak in China after eating contaminated donkey and goose meat. In ...